Bezafibrate Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer's Disease
Bezafibrate, a pan-peroxisome proliferator-activated receptor (PPAR) agonist, reportedly attenuated tau pathology in a transgenic mouse model of primary tauopathy. Since tau pathology is a neuropathological hallmark of Alzheimer's disease (AD), bezafibrate may be a potential drug for the treatm...
Saved in:
Main Authors: | Li-Fan Lin (Author), Yun-Ting Jhao (Author), Chuang-Hsin Chiu (Author), Lu-Han Sun (Author), Ta-Kai Chou (Author), Chyng-Yann Shiue (Author), Cheng-Yi Cheng (Author), Kuo-Hsing Ma (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemical degradation kinetics of fibrates: bezafibrate, ciprofibrate and fenofibrate
by: Marcelo Antonio de Oliveira, et al. -
Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer's Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways
by: Heba A. S. El-Nashar, et al.
Published: (2022) -
Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis
by: Yin Q, et al.
Published: (2015) -
Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis [Erratum]
by: Yin Q, et al.
Published: (2015) -
Chinese Herbal Extracts Exert Neuroprotective Effect in Alzheimer's Disease Mouse Through the Dopaminergic Synapse/Apoptosis Signaling Pathway
by: Qianqian Huang, et al.
Published: (2022)